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Summary: 6-[F-181Fluoro-L-3,4-dihydroxyphenylalanine (FDOPA) has been used to measure the central dopaminergic function in many species, including humans and monkeys. For transport across the blood brain barrier (BBB), FDOPA com petes with plasma large neutral amino acids (LNAA) . In this article we evaluate the effects of normal physiological LNAA concentration variation on BBB transport (Kl) and the FDOPA uptake measurement, Ki. We also investigate a method for reducing the dependency of FDOPA quantitation on LNAA.
Adult vervet monkeys (Cercopithecus aethiops sabaeus, n = 19) were fasted overnight before FDOP A positron emission tomography scans. Blood samples were drawn for LNAA de termination, metabolite analysis, and compartmental modeling.
6-[F-18]Fluoro-L-3,4-dihydroxyphenylalanine (FDOP A) is a biochemical probe used as a marker of central dopaminergic function in rats, monkeys, and hu mans. Low FDOP A uptake has been correlated with do pamine deficiencies due to Parkinson's disease (Snow et aI., 1993) and MPTP exposure (CaIne et aI., 1985; Chiueh et aI., 1985; Melega et aI., 1991; Doudet et aI., 1989) . While the magnitude of FDOP A uptake decreases markedly in severe disease or MPTP exposure, changes in the early disease stage and experimental treatments
The estimated K 1 and Ki were both negatively correlated with LNAA concentrations (r 2 = 0.51 and 0.62, respectively). Us ing an adjustment to Kl and Ki based on these correlations, the LNAA dependency was reduced (SD of the data for K1 was reduced by 33%, for Ki by 40%). Experiments with amino acid loading on an additional six animals indicate that BBB trans port can be described using Michaelis-Menten kinetics. Results show a clear dependence of FDOP A uptake on plasma LNAA concentrations, which can be removed to increase the precision of FDOPA quantitation. Key Words: Positron emission to mography-6-[F-181fluoro-L-DOPA-Large neutral amino acids-Non-human primate.
that potentially modify dopaminergic loss or regenera tion are usually small and subtle. Therefore, the ability to distinguish small changes in signal strength is crucial for accurate diagnosis and measuring experimental efficacy.
FDOP A positron emission tomographic (PET) data are generally quantified with the use of a compartmental model to estimate the uptake constant Ki, where Ki = (Kl * k3)/(k2 + k3). The compartmental model for FDOPA (Huang et aI., 1991) is shown in Fig. 1 , using K 1 as the forward rate constant representing the blood brain barrier (BBB) transport, k2 as the reverse BBB transport rate constant, and k3 as the decarboxylation rate of FDOPA to fluorodopamine (FDA). FDOPA PET experi ments typically measure the accumulation kinetics of FDA in the striatum (Firnau et aI., 1986; Melega et aI., 1991; Huang et aI., 1991) .
FDOPA crosses the BBB via carrier-mediated tranS port (Cheng et aI., 1993) , commonly referred to as the large neutral amino acid (LNAA) transport system (01dendorf et aI., 1971 ). The LNAA system operates near saturation under normal biologic conditions (Oldendorf et aI., 1971; Smith et aI., 1987) , with all substrates com peting for the same binding site. This competition for FIG. 1. Compartmental model for FDOPA kinetics. The striatum has three compartments, tissue FDOPA, tissue fluorodopamine (FDA) and tissue 3-0MFD. The rate constants K1, k2 and K5, k6 represent BBB transport, forward and reverse transport of FDOPA and 3-0MFD, respectively. K3 is the decarboxylation of FDOPA to FDA and k4 is the clearance rate of FDA and its metabolites to plasma. transport suggests that FDOPA availability in the brain may be inversely related to plasma LNAA concentra tions. Competitive inhibition experiments using rela tively large amounts of a single amino acid (Hartvig et aI., 1993; Koeppe et aI., 1991; Shulkin et aI., 1995 ; Wade et aI., 1975) or infusion of multiple LNAA (Alexander et aI., 1994) have shown a decrease in uptake of both natu ral and synthetic LNAA probes. L-DOPA and FDOPA have also shown decreased uptake with the addition of large amounts of competitive substrates (Leenders et aI., 1986; Hartvig et aI., 1993) . However, normal variances in physiological plasma LNAA concentrations on FDOPA quantitation have not yet been investigated.
This article describes the effects of normal physiologic variations in LNAA concentrations on the quantitation of FDOP A in vervet monkeys (Cerco p ithecus aethio p s sa baeus). The correlations of LNAA concentrations with various FDOP A kinetic parameters, including the rate constants Ki and Kl, are described. Further, the effects of increasing plasma LNAA concentrations were evalu ated in animals and the effects on FDOP A quantitation characterized. The results suggest that the plasma LNAA dependency of FDOP A transport and uptake can be ad justed by a simple model, which can improve the preci sion of FDOP A quantitation and increases the sensitivity to the detection of small changes in the FDOP A mea surements.
METHODS

Chemistry
FDOPA (specific actlVlty 1 to 2 Ci/mmol) was produced on-site using the procedure previously described (Luxen et aI., 1990) . Chemical and radiochemical purities were >99%.
Positron emission tomography scanning
All experiments were conducted using a standard protocol described previously (Barrio et aI., 1990; Melega et aI., 1996) . A Siemens 713 PET scanner was used to acquire 28 dynamic scans from 25 vervet monkeys. A transmission scan using a Ge-68 ring source was used to measure attenuation correction factors for the emission scans. All animals received 10 to 15 mg/kg subcutaneous carbidopa 45 minutes before FDOP A in jection. Each animal received approximately 1.0 mCi/Kg FDOP A injected intravenously as a bolus over 45 seconds.
J Cereb Blood Flow Metab. Vol. 18, No.1. 1998 During the first 30 minutes, dynamic data was acquired with 13 frames (10 x 90 s and 3 x 300 s). For the remaining 90 minutes, an interleaved protocol alternated between two bed positions to acquire data in 18 x 300 s frames (9 frames for each bed position). The interleaved protocol doubled the axial sampling, producing a plane separation of 1.67 mm, which decreased the sensitivity of animal positioning relative to the scanner imaging planes. Arterial blood samples (0. 3 to 1.0 mL) for determining amino acid concentrations, rate constant modeling, and tracer metabolism were collected throughout the study, with 12 samples taken during the first 2 minutes and additional samples at 3, 4, 5, 10, 20, 45, 60, 90, 105 , and 120 minutes after injection. Blood samples were centrifuged and 100 fLL plasma samples assayed in a well counter (Tracor Analytic, Searle Analytical, Des Plains, IL, U.S.A.) for the plasma F-J8 time activity curves. Metabolite analysis was determined using the procedure previously described (Melega et aI., 1991) at 5, 10, 20, 30, 60, 90 , and 120 minutes after FDOP A injection.
LNAA determination
Plasma concentrations of seven LNAA (tyrosine, tryptophan, valine, phenylalanine, methionine, leucine, and isoleucine) were determined by HPLC analysis described earlier (Barrio et aI., 1986; Keen et al., J 989) . In brief, blood samples were drawn from an arterial catheter before FDOP A injection from overnight fasted vervet monkeys. Plasma was deproteinated with an equal volume of 0.8 mollL perchloric acid, filtered (0.22 fLm, Micron Alltech, Deerfield, IL, U.S.A.) and stored at -4°C for later analysis. Quantitation of the amino acids was achieved by a gradient HPLC analysis using a Beckman C-18 Ultrasphere (Beckman Instruments, Fullerton, CA, U.S.A.) re versed phase 5 fLm column (4.6 mm x 25 cm). The solvent flow was 0.8 mUmin with 70% 100 mmol/L NaH 2 P04, 30% MeOH, ramped to 65% MeOH by 30 minutes. After neutral ization with 0.3 mollL KOH and filtration of precipitated po tassium perchlorate, samples were incubated with an equal vol ume ofo-phthaldialdehyde solution (1 mg/mL, Sigma Chemi cal, St. Louis, MO) for 2 minutes before injection. Fluorescence detection using a 340 nm excitation wavelength and 440 nm emission detection provided stable, reproducible peak areas (Keen et aI., 1989) . Concentrations of each LNAA were determined by comparing peak areas with known dilu tions for each amino acid at 10, 20, and 100 fLmollL. The total plasma LNAA concentration was calculated as the sum of all seven LNAA.
LNAA loading experiments
The pharmacokinetics of infusing amino acids were tested on six animals using a 10% Travasol solution (Baxter Healthcare, Des Plains, IL, U.S.A.). Travasol is a commercially available intravenous feeding solution that contains all amino acids in a concentration ratio typical for humans. The 10% Travasol so lution was diluted to either 2.5% or 5% using sterile water before injection. Each monkey received an intravenous bolus injection of 12 mL of diluted Travasol over 3 minutes followed by the infusion rate listed in Table 1 . Blood samples were drawn before the Travasol injection and during the hour after injection to determine the fasted and increased LNAA concen trations, respectively.
All six animals had FDOP A PET scans acquired after or during the amino acid loading. The first three animals received a bolus and infusion with Travasol for a period of 20 minutes, followed 10 minutes later by the FDOP A injection. The second set of three animals received a bolus followed by continuous infusion during the entire PET experiment, with the tracer ad ministered 10 minutes after the start of the Travasol injection. Blood samples were drawn throughout the experiment to de- All animals received a 12 -mL bolus of either 2. 5% or 5% Travasol (Baxter Healthcare) over 3 minutes, followed by the infusion rate listed above. FDOPA was injected 10 minutes after the LNAA loading was completed for the 2. 5% Travasol experiments and 10 minutes after infusion start for the 5% experiments.
Increased LNAA values are the total micromolar concentrations of the seven LNAA from 0 to 20 minutes after FDOPA injection for the 2. 5% experiments and 0 to 120 minutes after FDOPA for the 5% experiments. FDOPA, 6-[F-1 8] Fluoro-L-3, 4-dihydroxyphenylalanine; LNAA, large neutral amino acid.
termine LNAA concentrations, time-dependent plasma radio activity, and tracer metabolite analysis.
Data analysis
Images were reconstructed using measured attenuation and a Hann filter (0.5 cutoff of the Nyquist frequency), yielding an in-plane image resolution of approximately 5.5 mm full width half maximum. Parametric images displaying the FDOP A up take constant Ki were determined with a Patlak analysis (Patlak et aI., 1983) using the plasma FDOPA radioactivity curve and PET data collected between 30 and 120 minutes after FDOPA injection. Background activity, due to the FDOPA metabolite 3-0-methyl-FDOPA (OMFD), was obtained using a region of interest (ROI) defined inside the cerebellum and was subtracted from the entire image, before the Patlak analysis, to generate parametric images of Ki.
Regions of interest were drawn on all parametric image planes containing striatal signal and the plane with the highest Ki value was used for analysis. Striatal and cerebellar radioac tivity concentrations were also determined at 120 minutes after injection. K1, k2, and k3 values of the striatal region were determined using the first 30 minutes of data based on the FDOPA model ( Fig. 1 ). An iterative least squares fitting algo rithm was used, where k3 was constrained by the striatal Ki value obtained from the Ki parametric images by the relation ship k3 = Ki * k2/(K1 -Ki). This constraint was necessary to stabilize the fitting results and produce convergence to non negative kinetic values. Using an unconstrained model pro duced nearly identical values for the data taken as a group; however, several experiments produced negative or extremely high rate constants or did not converge to a solution.
Large neutral amino acids concentrations for the amino acid loading studies were estimated as the average total LNAA con centrations of the measurements taken 10 to 50 minutes after FDOP A injection, which corresponds to the time when the majority of FDOPA uptake occurs. (Pardridge and Chio, 1986) .
RESULTS
Rate constants relationship to plasma
LNAA concentrations
Total LNAA concentrations averaged 426 /-LmollL (124 SD) for 19 overnight fasted animals. Ki and Kl values averaged 0.0080 mLimin/g (0.002) and 0.0315 mLimin/g (0.0046), respectively ( , r2 = 0.69), and the MM fit by 11 % (Vmax = 5.9, Km = 3lO, r 2 = 0.64, Fig. 3 ). Similar measures were obtained for Kl using a fit with all the experimental data, (Ki = 0.042 -2.38e -5 * [LNAA], r 2 = 0.59 and Vmax = 28.7, Km = 502, r 2 = 0.63). The addition of a diffusion component, Kd, in the MM model did not significantly alter the fitting results, as assessed by the lack of increase of the corre lation coefficient using a F-test at P > .05 level.
LNAA adjustment results
Ki values were adjusted for plasma LNAA concentra tions by the use of the fits shown in Fig. 2 . The linear adjustment used the following equation:
The adjusted Ki values are shown in Table 2 . These adjusted Ki values correspond to uniform plasma LNAA concentration of 426 /-LmoI/L, which is the average LNAA concentration in the 19 fasted animals. The SD of the adjusted Ki values among the 19 fasted studies de creased from 0.0020 mLimin/g to 0.0012 mLimin/g, rep resenting a 40% decrease in data variability. Similarly, when the Kl values were adjusted for plasma LNAA using the following equation, Kl variability decreased from 0.0046 mL/min/g to 0.0032 mLimin/g, a 30% de crease in the SD. Kl adjusted = K1 measured -2.6 X 10-5
Based on the relationship Ki = K I * k3/(k2 + k3), if Ki values were calculated using the KI values adjusted for LNAA, a significant residual correlation (Ki = 0.0097 -3.5e -6 * [LNAA], r 2 = 0.24, P < .01) re mained between LNAA concentrations and the Kl ad justed Ki values (Fig. 4) .
LNAA fractions unchanged with amino acid loading
The relative fraction of each LNAA was compared for all 19 fasted animals ( Table 3 ). The ratio of each amino acid to the total was found to be stable (SD 1.1 to 3.5%). The LNAA loading experiments increased total LNAA concentrations 25% to 190% above the fasted measure ments ( Table 1 ). The ratio of fasted total plasma LNAA concentrations to loaded LNAA values are shown in Fig.  5 . Over the duration of the six LNAA loading experi ments, the percent contribution for each LNAA remained nearly unchanged for all LNAA. There were small, sig- differences were -1 %, which was at the limit of the measurement sensitivity.
LNAA adjustment validation experiments
For the three animals studied without (fasted) and with (loaded) moderate amino acid loading, the Ki values for the loading experiments decreased on average by 36% compared to the fasted Ki values (Table 4 ). Using the linear based LNAA adjustment described above (Eq. 1), the difference between fasted and loading Ki values was significantly reduced for each of the three animals. The SD of the Ki values for all six experiments decreased from 37% to 15%.
Striatum-cerebellum ratios
The ratio of striatum to cerebellum (S/Cb) was deter mined at the end of each experiment. Figure 6A shows the individual ROI values for all experiments, normal ized for weight and dose. The correlation equations were striatal ROI (Image counts/pixel) = 0.096 -0.000057 * [LNAA], r 2 = 0.64 and cerebellar ROI = 0.047 -0.000027 * [LNAA], r 2 = 0.60. The S/Cb ratio is shown in Fig. 6B , along with the cerebellar value divided by the weight and dose adjusted plasma FDOPA + OMFD (C p ) at 120 minutes. The S/Cb ratio had no correlation with LNAA concentrations (r 2 = 0.007) whereas the cerebel lum to plasma ratio was related by the equation Cb/C p = 1. 11 -0.00063 * [LNAA], with r 2 = 0.59. The average value for the Cb/C p ratio was 0.77 for all experiments, 0.84 for all fasted experiments. The peripheral FDOP A metabolism was unaffected by amino acid loading, with all fractions of FDOPA and OMFD of the loading ex periments within one SD of the fasted values at all mea surement times.
DISCUSSION
LNAA correlation with kinetic parameters
The variability of FDOP A Ki values has been exam ined earlier (Vingerhoets et aI., 1996; Pate et aI., 199 1) .
However, the contribution of variations in LNAA con centrations within the normal physiologic range to the Ki variability has not been addressed. The present work shows a significant inverse correlation between LNAA and FDOP A Kl and Ki values at normal physiologic amino acid concentrations. These findings are in agree ment with the theory that FDOP A competes with LNAA for a common saturable BBB transporter site. Using this correlation to adjust the rate constants Kl and Ki, their dependency on the plasma LNAA concentrations can be reduced. The resulting values have a significantly lower SD, thereby improving the sensitivity of FDOP A for measuring central dopaminergic function.
LNAA administration
The sensitivity of FDOPA quantitation to the plasma LNAA concentrations (Fig. 3) suggests that plasma con centrations must be kept stable during FDOP A uptake to model transporter competition effects. If a higher LNAA concentration is desired, care must be exercised to achieve and maintain a constant level. Bolus injections produce a rapid elevation of plasma amino acid concen tration, followed by a decrease over several hours. To minimize the changing concentrations associated with a bolus delivery of amino acids, we used the bolus/infusion method previously described by Carson et al. (1993) . Using this method, we quickly established stable, in creased LNAA concentrations in six vervet monkeys. The concentrations of LNAA were measured at several times during the LNAA loading experiments (Fig. 5) .
Previous amino acid loading experiments have used either a single bolus injection (Koeppe et aI., 1991; Wade et aI., 1975; Hamrnerstad et aI., 1993; Hartvig et aI., 1993; Smith et a!., 1987) or various injections of multiple LNAA (Leenders et aI., 1986; Alexander et aI., 1994) to increase amino acid concentrations. The amino acid lev els reported were either the injected quantities, single 0.015 measurements, or values determined from hourly sam pling during the experiments. The kinetics of the LNAA concentrations during the uptake of the tracer were not determined. In contrast to previous work that showed a qualitative inverse relationship between LNAA concen trations and FDOP A uptake, the present investigation characterizes quantitatively the relationship between nor mal physiologic LNAA concentrations and FDOP A up take. Additionally, we have showed the necessity of ac curate LNAA plasma determinations, both for loading and fasted experiments, in order to remove the LNAA dependency from quantitative FDOP A measurements. In addition to the complication of using a bolus injec tion, other factors are known to effect plasma LNAA concentrations, including anesthesia (Sage et al., 1979; Berglund et al., 1991) , 1968; Scriver et al., 1985) , and individual metabolic variations (Scriver et al., 1985; Ber glund et al., 1991) . These factors are minimized in the present work by measuring the LNAA concentration dur ing FDOP A uptake.
LNAA adjustment validation: paired experiments
To test the validity of using the Ki-derived adjustment, we examined three animals both with and without amino acid loading. A comparison of results from fasted versus amino acid loading experiments is made in Table 4 . Un adjusted Ki values dropped by an average of 36% with the increased LNAA levels. Using a linear-based adjust ment derived from LNAA and Ki data in Fig. 4 , applied to both the fasted and elevated PET studies, the Ki varia tion between these two experiments was markedly re duced for each of the three animals (Table 4 ). This sig nificant decrease in Ki variability shows that the model is useful for removing the LNAA dependence and in creases measurement precision.
KI is not sufficient to describe LNAA effects
Using the LNAAeffects on KI alone to adjust the Ki value resulted in values still correlated to LNAA con centrations (Fig. 4) . This suggests that additional com ponents (i.e., in addition to the LNAA effect on KI) may be needed to adequately describe the LNAA effects on the estimated Ki values. If k2 is also affected by plasma LNAA similar to Kl, Ki would have had a lower depen dency on LNAA than Kl, instead of the larger depen dency as' determined in the present work. Because k3 is the aromatic amino acid decarboxylase rate for FDOP A inside the neuron, the passage of the tracer across the neuronal membrane is not explicitly accounted for in the FDOP A model. It is conceivable that the higher LNAA concentrations may also inhibit transport at a neuronal transporter (Barrio et aI., 1997) . However, with the pre sent data no correlation of either k2 or k3 with LNAA concentrations was clearly demonstrable, which indi cates the need for further work to address this issue.
Although the Kl correlation was not sufficient to re move all the LNAA dependency, it does account for a large portion of the Ki correlation. An adjustment based on the Ki correlation, however, best describes the LNAA dependency on the FDOP A uptake. Although there is some controversy over the correla tion of age with Ki values (Eidelberg et aI., 1993; Scher man et aI., 1989) , recent work with FDOP A and [F-18]phenylalanine (Kuwabara et aI., 1995; Ito et al., 1995) indicates that KI does not change with aging. This sug gests that the KI component of the LNAA adjustment can appropriately be applied to data acquired from ani mals of all ages. The limited range of animal ages used in the present work (7.7 ± 3 years) indicates no correla tion of plasma LNAA concentrations, K1, or Ki with age; however, the age range is not sufficiently wide to clearly characterize any age dependency. 
Michaelis-Menten kinetics versus linear fit
Carrier-mediated transport, including FDOPA and LNAA BBB transport, is expected to follow MM kinet ics. Because the difference between a linear and MM fit was not significant (P < .05) for the non loading experi ments, three animals were tested using a high LNAA loading to exam i ne the fit over a wider range of amino acid concentrations.
Based on a linear fit of the fasted PET data, the ad justed Ki values for the three highest LNAA loading studies were significantly higher (38%, P < .01) than the average fasted Ki value. The MM-derived adjustment produced Ki values 9% lower than the average, which was not significantly different from the average fasted K i value (P > .5). Similar results were determ i ned for the Kl rate constants. This suggests that the LNAA depen dency is best described using MM kinetics, especially over a wide range of LNAA concentrations. Further evi dence supporting the MM model is that the original MM fit remains relatively unchanged with the inclusion of all the LNAA loading experiments. Although the MM fit was best for a wide range of LNAA concentrations, in the normal physiologic range, a linear fit reasonably ap proximates the data. The adjusted KI and Ki values based on either fitting results are comparable for the set of studies without LNAA loading. Plasma LNAA Concentration (�M)
The addition of a diffusion parameter in the MM fit did not alter the fitting results. Estimates of the diffusion parameter (Smith et aI., 1987; Wade et aI., 1975) indicate that diffusion would not be a significant component in the LNAA concentration range of the present experi ments [175 to 1265 fLmollL, significantly lower than the 2-mmollL level necessary for the diffusion component to reach -10% (Smith et aI., 1987) ].
Individual amino acid binding affinities for the LNAA transporter vary widely (Oldendorf et aI., 1971) . The possibility exists that a change in the relative concentra tions of the various amino acids could alter the rate con stants owing to their different affinities. For the MM modeling of the present study, the Km is assumed to be a lumped constant for all seven LNAA, although each amino acid has its own transporter affinity (Hargreaves et aI., 1988) .
In the fasted studies, the ratio of each individual amino acid to the total LNAA concentration was stable among all the animals. Even for the relatively high amino acid loading experiments, the fractions of the seven LNAA remained nearly unchanged compared with the fractions of the fasted studies. Furthermore, the fractions of each amino acid also remained stable over the course of each loading experiment. This indicates that the LNAA con centrations in the Travasol solution are appropriately matched to the in vivo concentrations, that the MM model with a single Km value can be used, and that a summed LNAA concentration is an appropriate param eter for adjusting the K1 and Ki values. Attempts to calculate a weighted Km value using individual amino acid Km's determined from rat brain uptake indices measurements (Smith et. aI., 1987) Although species differences cannot completely be discounted, the difference in Km values may be attrib uted to the methodologic differences in the Km determi nation.
Striatum-cerebellum ratios
An alternative approach to assessing FDOPA activity is the use of the SICb ratio. As shown in Fig. 6B , the ratios are independent of LNAA concentrations. Figure  6A , however, shows that the striatal and cerebellar val ues are correlated with LNAA concentrations. The ratios appear unaffected because the LNAA concentration af fects both striatum and cerebellum in approximately the same magnitude. The striatal and cerebellar values used J Cereb Blood Flow Metab, Vol. 18, No. I, 1998 to measure these ratios are correlated with LNAA con centrations. This suggests that factors which alter only the specific or nonspecific dopaminergic distributions will produce ratios that do not accurately reflect the sta tus of the dopaminergic activity in the striatum.
Using conventional wisdom it is difficult to explain the decrease in cerebellar values with increasing LNAA concentrations. The CblC p ratio shown in Fig. 6B mainly indicates the distribution of OMFD at the time of the determination (2 hours after FDOP A injection). The av erage CblC p ratio (0.77) agrees well with the ratio of 0.677 reported in human occipital cortex using OMFD as an imaging agent (Dhawan et aI., 1996) . That the cer ebellum OMFD concentration is reduced at higher LNAA concentrations implies a reduction in the volume of distribution for the FDOP A metabolite. The reduced cerebellum to plasma ratio became stable in all cases starting at approximately 15 minutes after FDOP A injec tion and remained constant for the remaining 105 min utes of the experiment, suggesting that equilibrium has been achieved. A possible explanation for the decrease in distribution volume could be that the forward and reverse BBB transport are differentially effected by LNAA con centrations. The nature of the specific and nonspecific distribution of FDOP A and OMFD in brain tissue thus warrants further investigation.
CONCLUSION
Variations in the normal physiologic plasma concen trations of LNAA in fasted vervet monkeys have a marked effect on FDOPA quantitation. Using the corre lation between the plasma LNAA levels and FDOPA Ki values, it is possible to characterize and remove the de pendency of Ki on plasma amino acid concentrations. An adjustment for LNAA concentrations derived from a lin ear or MM fit of the K1 and Ki data significantly reduced the variability of the data. Both K1 and Ki standard de viations were lowered by about one third using the LNAA adjustment. The reduction was even greater with the increased LNAA concentrations. The LNAA adjust ment decreases the variability and improves the precision of FDOP A quantitation for the assessment of central do paminergic function.
